Quanterix Co. (NASDAQ:QTRX) Shares Purchased by Millennium Management LLC

Millennium Management LLC lifted its holdings in Quanterix Co. (NASDAQ:QTRX) by 6.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,185,101 shares of the company’s stock after purchasing an additional 122,969 shares during the quarter. Millennium Management LLC owned 5.67% of Quanterix worth $23,228,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Ameriprise Financial Inc. boosted its stake in Quanterix by 111.3% during the fourth quarter. Ameriprise Financial Inc. now owns 3,205,928 shares of the company’s stock valued at $34,079,000 after buying an additional 1,688,680 shares in the last quarter. William Blair Investment Management LLC bought a new position in Quanterix during the fourth quarter valued at about $11,290,000. Pier Capital LLC boosted its stake in Quanterix by 32.8% during the fourth quarter. Pier Capital LLC now owns 679,680 shares of the company’s stock valued at $7,225,000 after buying an additional 167,882 shares in the last quarter. Valmark Advisers Inc. boosted its stake in Quanterix by 88.3% during the fourth quarter. Valmark Advisers Inc. now owns 210,878 shares of the company’s stock valued at $2,242,000 after buying an additional 98,883 shares in the last quarter. Finally, Easterly Investment Partners LLC boosted its stake in Quanterix by 9.0% during the fourth quarter. Easterly Investment Partners LLC now owns 954,995 shares of the company’s stock valued at $10,152,000 after buying an additional 78,862 shares in the last quarter. Institutional investors own 86.48% of the company’s stock.

Quanterix Trading Up 2.5%

Shares of Quanterix stock opened at $4.99 on Wednesday. The stock has a 50-day moving average price of $5.78 and a 200 day moving average price of $8.69. The company has a market cap of $193.76 million, a P/E ratio of -4.71 and a beta of 1.12. Quanterix Co. has a 1 year low of $4.05 and a 1 year high of $19.18.

Quanterix (NASDAQ:QTRX) last announced its quarterly earnings data on Monday, May 12th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.69) by $0.16. The firm had revenue of $30.33 million during the quarter, compared to the consensus estimate of $28.27 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. On average, equities analysts forecast that Quanterix Co. will post -0.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on QTRX shares. Leerink Partnrs downgraded Quanterix from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a report on Tuesday, March 25th. Canaccord Genuity Group reduced their target price on Quanterix from $15.00 to $12.00 and set a “buy” rating for the company in a report on Tuesday, May 13th. Finally, Leerink Partners reaffirmed a “market perform” rating and set a $8.00 target price (down from $12.00) on shares of Quanterix in a report on Wednesday, April 30th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Quanterix currently has an average rating of “Moderate Buy” and a consensus price target of $15.60.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.